Psoriasis and Developmental reading disorder
Summary:
Developmental reading disorder is found among people with Psoriasis, especially for people who are male, 60+ old.
The study analyzes which people have Developmental reading disorder with Psoriasis. It is created by eHealthMe based on reports of 17 people who have Psoriasis from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.
What is Psoriasis?
Psoriasis (immune-mediated disease that affects the skin) is found to be associated with 1,473 drugs and 1,695 conditions by eHealthMe. Check the latest studies of Psoriasis.
What is Developmental reading disorder?
Developmental reading disorder is found to be associated with 141 drugs and 362 conditions by eHealthMe. Check the latest studies of Developmental reading disorder.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
17 people who have Psoriasis and Developmental Reading Disorder are studied.

Gender of people who have Psoriasis and experienced Developmental Reading Disorder *:
- female: 35.29 %
- male: 64.71 %
Age of people who have Psoriasis and experienced Developmental Reading Disorder *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 22.22 %
- 50-59: 33.33 %
- 60+: 44.44 %
Common co-existing conditions for these people *:
- Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 8 people, 47.06%
- Pain: 2 people, 11.76%
- Stress And Anxiety: 1 person, 5.88%
- Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 1 person, 5.88%
- High Blood Pressure: 1 person, 5.88%
Common drugs taken by these people *:
- Skyrizi: 4 people, 23.53%
- Humira: 3 people, 17.65%
- Cosentyx: 3 people, 17.65%
- Xeljanz Xr: 2 people, 11.76%
- Raptiva: 2 people, 11.76%
- Prozac: 2 people, 11.76%
- Leflunomide: 2 people, 11.76%
- Hydrochlorothiazide: 2 people, 11.76%
- Enbrel: 2 people, 11.76%
- Enalapril Maleate: 2 people, 11.76%
Common symptoms for these people *:
- Memory Loss: 4 people, 23.53%
- Hypokinesia (decreased bodily movement): 2 people, 11.76%
- Tooth Abscess (pus formation in tooth): 2 people, 11.76%
- Depression: 2 people, 11.76%
- Liver Disorder (liver diseases): 2 people, 11.76%
- Disturbance In Attention: 2 people, 11.76%
- Dizziness: 2 people, 11.76%
- Dyscalculia (impaired ability to learn grade-appropriate mathematics): 2 people, 11.76%
- Hypoacusis (loss of hearing): 2 people, 11.76%
- Fatigue (feeling of tiredness): 2 people, 11.76%
* Approximation only. Some reports may have incomplete information.
Do you take medications and have Developmental reading disorder?
- Check whether Developmental reading disorder is associated with a drug or a conditionRelated publications that referenced our studies
- Mohagheghi MA, Omranipur R, Ensani F, Ghannadan A, Shahriaran S, Samiee F, Sedighi Z, "A Case of Advanced Unicentric Retroperitoneal Castleman's Disease, Associated With Psoriasis", Acta Medica Iranica, 2017 May .
- Chiriac A, Brzezinski P, Stolnicu S, Podoleanu C, Moldovan C, Molnar C, Taranu T, "Eosinophilia–A rare possible adverse reaction during anti-tumor necrosis factor-alpha therapy for psoriasis", Journal of Dermatological Treatment, 2016 Mar .
- Malisiewicz B, Murer C, Schmid JP, French LE, Schmid-Grendelmeier P, Navarini AA, "Eosinophilia during psoriasis treatment with TNF antagonists", Dermatology, 2013 Jan .
- Mohagheghi MA, Omranipur R, Ensani F, Ghannadan A, Shahriaran S, Samiee F, Sedighi Z, "A Case of Advanced Unicentric Retroperitoneal Castleman's Disease, Associated With Psoriasis", Acta Medica Iranica, 2017 May .
- Chiriac A, Brzezinski P, Stolnicu S, Podoleanu C, Moldovan C, Molnar C, Taranu T, "Eosinophilia–A rare possible adverse reaction during anti-tumor necrosis factor-alpha therapy for psoriasis", Journal of Dermatological Treatment, 2016 Mar .
- Malisiewicz B, Murer C, Schmid JP, French LE, Schmid-Grendelmeier P, Navarini AA, "Eosinophilia during psoriasis treatment with TNF antagonists", Dermatology, 2013 Jan .
Related studies:
Treatments, associated drugs and conditions:
- Psoriasis (508,164 reports)
- Developmental reading disorder (1,463 reports)
All the drugs that are associated with Developmental reading disorder:
- Developmental reading disorder (141 drugs)
All the conditions that are associated with Developmental reading disorder:
- Developmental reading disorder (362 conditions)
How the study uses the data?
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
The study is based on Developmental reading disorder and Psoriasis, and their synonyms.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Pancreatin cause Abdominal Distension? - 2 seconds ago
- Could Zenpep cause Pancreatic Carcinoma? - 3 seconds ago
- Could Alprazolam cause Rhonchi? - 5 seconds ago
- Could Efavirenz cause Skin Blushing/Flushing? - 5 seconds ago
- Could Zolpidem cause Borderline Personality Disorder? - 6 seconds ago
- Could Xyrem cause The Flu? - 8 seconds ago
- Could Temazepam cause Collapse Of Lung? - 9 seconds ago
- Drug interactions of Daytrana and Remicade - 15 seconds ago
- Could Rivastigmine cause International Normalised Ratio Increased? - 15 seconds ago
- Could Nucynta cause Swallowing Difficulty? - 16 seconds ago